Tuoxin Pharmaceutical: Wholly-owned subsidiary obtains CNAS laboratory accreditation certificate
Tuoxin Pharmaceutical announced that its wholly-owned subsidiary, Henan Nucleoside Drug Research Institute Co., Ltd., recently received a laboratory accreditation certificate granted by the China National Accreditation Service for Conformity Assessment. The name of the accredited organization is Henan Nucleoside Drug Research Institute Co., Ltd., and the registration number of the testing and inspection center is CNAS L23965, with an effective date of September 1, 2025, and an expiration date of August 31, 2031
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments